1 Min Read
March 30 (Reuters) - Horizon Pharma Plc:
* Horizon Pharma Plc - borrowed $850 million aggregate principal amount of loans pursuant to an amendment to credit agreement, dated as of May 7, 2015
* Horizon Pharma Plc - interest rate applicable to refinancing loans is libor plus 3.75%, subject to a libor floor of 1.0%.
* Horizon Pharma Plc - proceeds of refinancing loans to repay refinanced loans, which totaled $769 million - SEC filing Source text: (bit.ly/2nOKIlr) Further company coverage: